Detailansicht

Wissensnetz

Person

Matthias Americo Villalobos Bollen (1974-)

Arzt

Name	Matthias Americo Villalobos Bollen
Zeit	1974- (Lebensdaten)
Ort	Lima (Geburtsort) Heidelberg (Wirkungsort) Peru Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. med. (an der Medizinischen Fakultät Heidelberg der Ruprecht-Karls-Universität) (2020)
Beruf	Arzt (charakteristischer Beruf)
Variante	Matthias Villalobos Matthias Americo Villalobos Bollen Matthias Americo Villalobos-Bollen
Beziehung	Klinikum Heidelberg Thoraxklinik Heidelberg (2011-) Ludolf-Krehl-Klinik (2000 - 2009) Hämatologie (Thema) Onkologie (Thema) Thoraxtumor (Thema)
Quelle	Homepage: https://www.thoraxklinik-heidelberg.de/index.php?id=424&L=&FS=target%3D_self (Stand: 19.05.2020)
Datensatztyp	Person
GND-Nummer	1078644306
Datensatz-ID	1078644306
Beteiligt an alle anzeigen SOP – Schmerztherapie bei Patienten mit einer Tumorerkrankung in Palliativsituation HELP — Heidelberg decision aid for lung cancer patients: a randomized controlled clinical trial Factors related to implementation of an interprofessional communication concept in thoracic oncology: a mixed-methods study Heidelberger Meilenstein Kommunikation (HeiMeKOM) – Erfahrungen, Best Practice Beispiele und Empfehlungen aus dem Abschluss-Symposium am 30./31. Januar 2020 Lung cancer patients’ comorbidities and attendance of German ambulatory physicians in a 5-year cross-sectional study Consideration of sense of coherence in a structured communication approach with stage IV lung cancer patients and their informal caregivers: a qualitative interview study Patient expectations are better for immunotherapy than traditional chemotherapy for cancer Implementation of the milestones communication approach for patients with limited prognosis: evaluation of intervention fidelity Cancer Patients’ Preferences for either Quality of Life or a Longer Life Determine Their Willingness to Talk about Forgoing Cancer-Specific Treatment Communication along Milestones in Lung Cancer Patients with Advanced Disease Kommunikation entlang der Behandlungsmeilensteine bei Patienten mit fortgeschrittenem Lungenkrebs Stellenwert von Biomarkern der DNA-Reparatur und der epithelialen-mesenchymalen Transition beim fortgeschrittenen nicht-kleinzelligen Lungenkarzinom The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer Reflection of illness and strategies for handling advanced lung cancer – a qualitative analysis in patients and their relatives Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Matthias Americo Villalobos Bollen (1974-)

SOP – Schmerztherapie bei Patienten mit einer Tumorerkrankung in Palliativsituation

HELP — Heidelberg decision aid for lung cancer patients: a randomized controlled clinical trial

Factors related to implementation of an interprofessional communication concept in thoracic oncology: a mixed-methods study

Heidelberger Meilenstein Kommunikation (HeiMeKOM) – Erfahrungen, Best Practice Beispiele und Empfehlungen aus dem Abschluss-Symposium am 30./31. Januar 2020

Lung cancer patients’ comorbidities and attendance of German ambulatory physicians in a 5-year cross-sectional study

Consideration of sense of coherence in a structured communication approach with stage IV lung cancer patients and their informal caregivers: a qualitative interview study

Patient expectations are better for immunotherapy than traditional chemotherapy for cancer

Implementation of the milestones communication approach for patients with limited prognosis: evaluation of intervention fidelity

Cancer Patients’ Preferences for either Quality of Life or a Longer Life Determine Their Willingness to Talk about Forgoing Cancer-Specific Treatment

Communication along Milestones in Lung Cancer Patients with Advanced Disease

Kommunikation entlang der Behandlungsmeilensteine bei Patienten mit fortgeschrittenem Lungenkrebs

Stellenwert von Biomarkern der DNA-Reparatur und der epithelialen-mesenchymalen Transition beim fortgeschrittenen nicht-kleinzelligen Lungenkarzinom

The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial

ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer

Reflection of illness and strategies for handling advanced lung cancer – a qualitative analysis in patients and their relatives

Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients